This is additional protocol for biopsy specimen.
OPTIONAL: Expert Consultation before completion of the reporting.
- Tumor histology and immunohistochemical studies:
Other ancillary investigations included ALK mutation and amplification, ATRX mutation, etc.
- International Neuroblastoma Pathology Classification (INPC): Favorable histopathology Unfavorable histopathology Cannot be determined
Cannot be assessed Uninvolved by tumor, closest bone margin, specify distance (mm): Uninvolved by tumor, closest soft tissue margin, specify distance (mm): Uninvolved by tumor, closest margin, specify distance and locations (mm): Involved by invasive carcinoma, specify margins:
International Neuroblastoma Risk Group (INRG) Staging System (INRGSS)
- + Additional pathologic findings: